![Joseph Slattery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Slattery
Direktor/Vorstandsmitglied bei
REPLIMUNE GROUP, INC.
Vermögen: 371 673 $ am 31.05.2026
Profil
Joseph P.
Slattery is currently Lead Independent Director at CVRx, Inc. since 2008.
Independent Director at Replimune Group, Inc. since 2017.
Director at Morphic Therapeutic, Inc. since 2019.
Independent Director at ImageneBio, Inc. since 2025.
Member of the Virginia Society of Certified Public Accountants.
Formerly Independent Director at Amgen Rockville, Inc. from 2011 to 2012.
Director at Exosome Diagnostics, Inc. from 2013 to 2018.
Independent Director at Omega Alpha SPAC.
Director at Micromet, Inc. Independent Director at Morphic Holding, Inc. from 2019 to 2024.
Chief Financial Officer & SVP-Information Systems at Digene Corp.
from 2006 to 2007.
Staff Auditor at Ernst & Young LLP.
Audit Manager at KPMG LLP.
CFO, Executive VP & Head-Investor Relations at Baxano Surgical, Inc. from 2012 to 2013.
Chief Financial Officer & Executive Vice President at SafeStitch Medical, Inc. in 2013.
CFO, Chief Accounting Officer & EVP at Asensus Surgical, Inc. from 2013 to 2019.
Chief Financial Officer & Executive Vice President at TransEnterix, Inc. from 2013 to 2019.
Education includes an undergraduate degree from Bentley University, conferred in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CVRX, INC. 0,15 % | 01.06.2026 | 39.365 ( 0,15 % ) | 219 657 $ | 31.05.2026 |
0,14 % | 16.06.2026 | 16.000 ( 0,14 % ) | 94 080 $ | 31.05.2026 |
REPLIMUNE GROUP, INC. 0,01 % | 01.04.2026 | 6.667 ( 0,01 % ) | 57 936 $ | 31.05.2026 |
Aktive Positionen von Joseph Slattery
| Unternehmen | Position | Beginn |
|---|---|---|
| CVRX, INC. | Direktor/Vorstandsmitglied | 01.10.2008 |
| REPLIMUNE GROUP, INC. | Direktor/Vorstandsmitglied | 01.10.2017 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Direktor/Vorstandsmitglied | 01.05.2019 |
Virginia Society of Certified Public Accountants | Corporate Officer/Principal | 28.06.2010 |
Ehemalige bekannte Positionen von Joseph Slattery
| Unternehmen | Position | Ende |
|---|---|---|
| MORC HOLD | Direktor/Vorstandsmitglied | 16.08.2024 |
| ASENSUS SURGICAL, INC. | Finanzdirektor/CFO | 31.12.2019 |
TransEnterix, Inc. /Old/
 TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Finanzdirektor/CFO | 01.12.2019 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Direktor/Vorstandsmitglied | 01.01.2018 |
SafeStitch Medical, Inc.
 SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Finanzdirektor/CFO | 09.12.2013 |
Ausbildung von Joseph Slattery
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Digene Corp.
 Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Electronic Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
TransEnterix, Inc. /Old/
TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
TranS1, Inc.
 TranS1, Inc. Medical SpecialtiesHealth Technology Designs and develops surgical procedures and equipment for back pain | Health Technology |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Virginia Society of Certified Public Accountants | |
SafeStitch Medical, Inc.
SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Asensus Surgical, Inc.
 Asensus Surgical, Inc. Packaged SoftwareTechnology Services Develops digital and robotic-assisted surgical systems | Technology Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Omega Alpha SPAC
 Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
